Cytomx Therapeutics Stock Technical Analysis

CTMX Stock  USD 1.68  0.01  0.60%   
As of the 24th of April, CytomX Therapeutics shows the Risk Adjusted Performance of 0.0295, mean deviation of 3.48, and Downside Deviation of 4.34. CytomX Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for nineteen technical drivers for CytomX Therapeutics, which can be compared to its peers. Please confirm CytomX Therapeutics variance and potential upside to decide if CytomX Therapeutics is priced correctly, providing market reflects its regular price of 1.68 per share. Please also double-check CytomX Therapeutics total risk alpha, which is currently at (0.60) to validate the company can sustain itself at a future point.

CytomX Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as CytomX, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CytomX
  
CytomX Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

CytomX Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
2.49Hold7Odds
CytomX Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most CytomX analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CytomX stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CytomX Therapeutics, talking to its executives and customers, or listening to CytomX conference calls.
CytomX Analyst Advice Details
CytomX Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of CytomX Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CytomX Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

CytomX Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of CytomX Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

CytomX Therapeutics Trend Analysis

Use this graph to draw trend lines for CytomX Therapeutics. You can use it to identify possible trend reversals for CytomX Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual CytomX Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

CytomX Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for CytomX Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.01  , which means CytomX Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 3.04, which is the sum of squared deviations for the predicted CytomX Therapeutics price change compared to its average price change.

About CytomX Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of CytomX Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of CytomX Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on CytomX Therapeutics price pattern first instead of the macroeconomic environment surrounding CytomX Therapeutics. By analyzing CytomX Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of CytomX Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to CytomX Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Dividend Yield0.03360.0299
Price To Sales Ratio1.131.07

CytomX Therapeutics April 24, 2024 Technical Indicators

Most technical analysis of CytomX help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CytomX from various momentum indicators to cycle indicators. When you analyze CytomX charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

CytomX Therapeutics April 24, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as CytomX stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether CytomX Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CytomX Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytomx Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytomx Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CytomX Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For more information on how to buy CytomX Stock please use our How to Invest in CytomX Therapeutics guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for CytomX Stock analysis

When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is CytomX Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CytomX Therapeutics. If investors know CytomX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CytomX Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Revenue Per Share
1.371
Quarterly Revenue Growth
0.322
Return On Assets
(0.02)
Return On Equity
(54.75)
The market value of CytomX Therapeutics is measured differently than its book value, which is the value of CytomX that is recorded on the company's balance sheet. Investors also form their own opinion of CytomX Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CytomX Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CytomX Therapeutics' market value can be influenced by many factors that don't directly affect CytomX Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CytomX Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CytomX Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CytomX Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.